State it in the SAP & observe it [Design Issues]

posted by Helmut Homepage – Vienna, Austria, 2021-03-29 18:08 (125 d 14:03 ago) – Posting: # 22298
Views: 931

Hi Loky do,

» If subject during bioequivalence study suffered from diarrhea before 2 median Tmax of immediate-release drug product, in this case, the optimum action to be done to exclude the subject from the study after the event directly?

If you know the median tmax:-D Sometimes in the label / SmPC for unfathomable reasons the mean is given.
State in the statistical analysis plan, and follow it (analyse the samples anyway).

» or subject continues the study and excludes his results from the calculations if his plasma concentration-time profile is unreliable?

I would not recommend that. Who / how decides what is ‘unreliable’? May lead to endless & fruitless discussions.

Dif-tor heh smusma 🖖
Helmut Schütz

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes

Complete thread:

 Admin contact
21,596 posts in 4,516 threads, 1,532 registered users;
online 14 (0 registered, 14 guests [including 2 identified bots]).
Forum time: Monday 08:11 CEST (Europe/Vienna)

Imagine if every Thursday your shoes exploded
if you tied them the usual way.
This happens to us all the time with computers,
and nobody thinks of complaining.    Jef Raskin

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz